29-May-2023 | D | Board Meeting Outcome for Outcome Of 85Th Board Meeting (29.05.2023)
Board of Directors has recommended a dividend of ?1.50/- (15%) per equity share of ?10/- face value, for the year 2022-23, subject to the approval of the Shareholders. | 22-Sep-2023 | |
28-May-2022 | D | SMS Lifesciences India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2022, inter alia, has recommended a dividend of Rs. 1.50/- (15%) per equity share Rs. 10/- face value, for the year 2021-22, subject to the approval of the Shareholders at the ensuing 16th Annual General Meeting (AGM) of the Company.
| 22-Sep-2022 | |
18-Jun-2021 | D | SMS Lifesciences India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 18, 2021, inter alia, have recommended a dividend of Rs. 1.50/- (15%) per equity share of Rs. 10 face value for the Financial year 2020-21. The dividend will be paid on or after five days from the date of approval by the shareholders at the 15th Annual
General Meeting (AGM). | 20-Sep-2021 | |
29-May-2019 | D | Recommended a dividend of Rs.1.50 (15 %) per equity share of Rs.lO / - (Rupees ten) each (face value), for the financial year ended 31 st March, 2019. The dividend will be paid subject to the approval of the shareholders at the ensuing Annual General Meeting. | 19-Sep-2019 | |
25-Apr-2024 | BC | Suresh Babu Potluri
(Sale Dated on: 01/04/2024 to 19/04/2024) | 01-Apr-2024 | |
15-Dec-2023 | BC | Source: BSE Announcement PDF
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 25, 20 | 25-Mar-2024 | |
20-Dec-2023 | BC | Source: BSE Announcement PDF
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 25, 20 | 25-Mar-2024 | |
03-Feb-2024 | BC | SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2024 inter alia to consider and approve 1. Unaudited financial results (Stan | 10-Feb-2024 | |
30-Dec-2023 | BC | TV Praveen
| 28-Dec-2023 | |
Announcement Date29-May-2023
Ex Dividend Date22-Sep-2023
Dividend(%)15
Announcement Date28-May-2022
Ex Dividend Date22-Sep-2022
Dividend(%)15
Announcement Date18-Jun-2021
Ex Dividend Date20-Sep-2021
Dividend(%)15
Announcement Date29-May-2019
Ex Dividend Date19-Sep-2019
Dividend(%)15
No Bonus has been declared by SMSLIFE
No Split has been declared by SMSLIFE
RightsNo Rights has been declared by SMSLIFE
Book Closure
01-Apr-2024 | - | Suresh Babu Potluri
(Sale Dated on: 01/04/2024 to 19/04/2024) |
25-Mar-2024 | 01 Jan'1900 | Source: BSE Announcement PDF
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 25, 20 |
25-Mar-2024 | 01 Jan'1900 | Source: BSE Announcement PDF
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 25, 20 |
10-Feb-2024 | - | SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2024 inter alia to consider and approve 1. Unaudited financial results (Stan |
28-Dec-2023 | - | TV Praveen
|